News & Events

TA Associates Announces Investment in Biocomposites

6 June 2017

biocomposites

TA Associates, a leading global growth private equity firm, has today announced it has completed an investment in Biocomposites, a manufacturer and marketer of calcium compound biologics.

TA will focus on supporting Biocomposites’ growth and building further value in the business.  Financial terms of the transaction were not disclosed.

Biocomposites is singularly focused on the development of innovative calcium compounds for surgical use.  Their bone graft matrices can be used in the presence of infection for regenerating bone and managing dead space in a range of orthopedic procedures.

Biocomposites sells directly to hospitals and through independent distributors, with the United States representing its largest market.  

Research, manufacturing and distribution is handled in-house at the company’s headquarters at Keele University Science and Innovation Park.  Sales representative offices are also maintained in Wilmington, North Carolina and Shanghai, China.

About TA Associates
TA Associates is one of the largest and most experienced global growth private equity firms.  The firm has invested in more than 480 companies around the world and has raised $24 billion in capital.  With offices in Boston, Menlo Park, London, Mumbai and Hong Kong, TA Associates leads buyouts and minority recapitalizations of profitable growth companies in the business services, consumer, financial services, healthcare and technology industries.  More information about TA Associates can be found at www.ta.com.